Urovant Sciences Ltd. (UROV) has 60 open-market insider trades by 14 insiders since 2018. The most active filer is Patrick Machado, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Patrick Machado | 10% Owner | — | 22 | $39.5M | 2019-06-19 |
| Andrew Lo | 10% Owner | — | 18 | $39.4M | 2019-06-19 |
| Ole Andreas Halvorsen | 10% Owner | — | 5 | $37.9M | 2019-06-19 |
| Sumitovant Biopharma Ltd. | 10% Owner | — | 1 | $2.7M | 2020-02-19 |
| Keith Katkin | CEO | — | 1 | $1.5M | 2020-02-19 |
| QVT Associates GP LLC | 10% Owner | — | 2 | $248K | 2019-06-14 |
| Rose Sharon Shabet | 10% Owner | — | 3 | $177K | 2019-06-14 |
| Dexxon Holdings Ltd. | 10% Owner | — | 2 | $168K | 2019-05-29 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | — | 1 | $163K | 2019-06-05 |
| Roivant Sciences Ltd. | 10% Owner | — | 1 | $163K | 2019-06-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sumitovant Biopharma Ltd. | 10% Owner | Buy | $2.7M | 2020-02-19 |
| Keith Katkin | CEO | Sell | $1.5M | 2019-12-09 |
| Andrew Lo | 10% Owner | Buy | $55K | 2019-06-18 |
| Patrick Machado | 10% Owner | Buy | $303K | 2019-06-17 |
| QVT Financial Investment Cayman Ltd. | 10% | Buy | $151K | 2019-06-17 |
| Ole Andreas Halvorsen | 10% Owner | Buy | $262K |
Companies that share insiders with UROV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-06-17 |
| Andrew Lo | 10% Owner | Buy | $56K | 2019-06-17 |
| Rose Sharon Shabet | 10% Owner | Buy | $57K | 2019-06-14 |
| Rose Sharon Shabet | 10% Owner | Buy | $59K | 2019-06-13 |
| Dexcel Pharma Technologies Ltd. | 10% | Buy | $177K | 2019-06-12 |
| Patrick Machado | 10% Owner | Buy | $62K | 2019-06-12 |
| Patrick Machado | 10% Owner | Buy | $355K | 2019-06-12 |